ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

HALO Halozyme Therapeutics Incorporated

38.71
-0.06 (-0.15%)
最終更新日: 00:02:31
15分遅延
名称 銘柄コード 市場 種別
Halozyme Therapeutics Incorporated HALO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.06 -0.15% 38.71 00:02:31
始値 安値 高値 終値 前日終値
38.54 38.50 39.03 38.77
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2605:45PRNUSMahesh Krishnan Elected to Halozyme's Board of Directors
2024/4/2321:30PRNUSHalozyme to Report First Quarter 2024 Financial and..
2024/3/0506:13EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/2/2908:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2906:07EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2807:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2807:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2807:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:08EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2722:30PRNUSHalozyme to Participate in Upcoming Investor Conferences
2024/2/2108:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2108:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2108:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2108:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2106:03EDGAR2Form 8-K - Current report
2024/2/2106:01PRNUSHALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL..
2024/2/1707:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1220:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0906:30PRNUSHalozyme To Report Fourth Quarter and Full Year 2023..
2024/1/3006:15PRNUSHalozyme Announces Takeda Received European Commission..
2024/1/2401:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1906:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1822:30PRNUSHalozyme Announces argenx Received Approval in Japan for..
2024/1/1806:56EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1722:10EDGAR2Form 8-K - Current report
2024/1/1706:26EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1622:15PRNUSHalozyme Announces Takeda Receives FDA Approval for HYQVIA®..
2024/1/1615:15PRNUSHalozyme Announces Roche Receives European Commission..
2024/1/1223:25PRNUSHalozyme to Host Investor Business Forum and Long-Term..
2024/1/0606:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1409:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1406:40EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1306:21EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2722:00PRNUSHalozyme to Present at Upcoming Investor Conferences
2023/11/1706:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1623:00PRNUSHalozyme Announces argenx Receives European Commission..
2023/11/1606:17EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1506:19EDGAR2Form 144 - Report of proposed sale of securities
2023/11/0706:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0706:04EDGAR2Form 8-K - Current report
2023/11/0706:01PRNUSHALOZYME REPORTS THIRD QUARTER 2023 FINANCIAL AND OPERATING..
2023/11/0621:30PRNUSHalozyme and Acumen Pharmaceuticals Enter Global..
2023/10/3107:35PRNUSHalozyme To Report Third Quarter 2023 Financial and..
2023/10/1920:15PRNUSPositive Topline Results Reported from Bristol Myers..

最近閲覧した銘柄

Delayed Upgrade Clock